Charles Schwab Investment Management »

Denali Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 1.0M 20.52
2023-12-31 $22M 1.0M 21.46
2023-09-30 $20M 981k 20.63
2023-06-30 $26M 868k 29.51
2023-03-31 $19M 836k 23.04
2022-12-31 $23M 837k 27.81
2022-09-30 $22M 731k 30.69
2022-06-30 $22M 732k 29.43
2022-03-31 $23M 704k 32.17
2021-12-31 $32M 717k 44.60
2021-09-30 $36M 704k 50.45
2021-06-30 $50M 640k 78.44
2021-03-31 $32M 566k 57.10
2020-12-31 $41M 493k 83.76
2020-09-30 $17M 486k 35.83
2020-06-30 $11M 471k 24.18
2020-03-31 $7.3M 419k 17.51
2019-12-31 $6.5M 375k 17.42
2019-09-30 $5.6M 367k 15.32
2019-06-30 $7.3M 353k 20.76
2019-03-31 $7.9M 339k 23.22
2018-12-31 $6.7M 322k 20.66
2018-09-30 $7.1M 325k 21.74
2018-06-30 $1.2M 80k 15.25
2018-03-31 $1.3M 66k 19.70